Type II inhibition of JAK2 with NVP-CHZ868 reverses type I JAK inhibitor persistence and demonstrates increased efficacy in MPN models Meeting Abstract
| Authors: | Meyer, S. C.; Keller, M. D.; Koppikar, P.; Guryanova, O. A.; Kleppe, M.; McKenney, A. S.; Sellers, W. R.; Hofmann, F.; Baffert, F.; Gaul, C.; Radimerski, T.; Levine, R. L. |
| Abstract Title: | Type II inhibition of JAK2 with NVP-CHZ868 reverses type I JAK inhibitor persistence and demonstrates increased efficacy in MPN models |
| Meeting Title: | 56th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 124 |
| Issue: | 21 |
| Meeting Dates: | 2014 Dec 6-9 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2014-12-06 |
| Language: | English |
| ACCESSION: | WOS:000349243500143 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V124.21.160.160 |
| Notes: | Meeting Abstract: 160 -- 56th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2014 -- San Francisco, CA -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work